Publications:

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer.

Frontiers In Pharmacology

Huang, Lu L; Liao, Zhi Z; Liu, Zhixi Z; Chen, Yan Y; Huang, Tingwenli T; Xiao, Hongtao H

Publication Date: 2022

Variant appearance in text: RET: h840a

PubMed Link: 35620280

Variant Present in the following documents:

• Main text
• fphar-13-900825.pdf

View BVdb publication page

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?

Cancers

Fuziwara, Cesar Seigi CS; de Mello, Diego Claro DC; Kimura, Edna Teruko ET

Publication Date: 2022-02-08

Variant appearance in text: RET: H840A

PubMed Link: 35159110

Variant Present in the following documents:

• Main text
• cancers-14-00844.pdf

View BVdb publication page

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?

Cancers

Fuziwara, Cesar Seigi CS; de Mello, Diego Claro DC; Kimura, Edna Teruko ET

Publication Date: 2022-02-08

Variant appearance in text: RET: H840A

PubMed Link: 35159110

Variant Present in the following documents:

• Main text
• cancers-14-00844.pdf

View BVdb publication page

The road ahead in genetics and genomics.

Nature Reviews. Genetics

McGuire, Amy L AL; Gabriel, Stacey S; Tishkoff, Sarah A SA; Wonkam, Ambroise A; Chakravarti, Aravinda A; Furlong, Eileen E M EEM; Treutlein, Barbara B; Meissner, Alexander A; Chang, Howard Y HY; López-Bigas, Núria N; Segal, Eran E; Kim, Jin-Soo JS

Publication Date: 2020-10

Variant appearance in text: RET: H840A

PubMed Link: 32839576

Variant Present in the following documents:

• Main text
• 41576_2020_Article_272.pdf

View BVdb publication page